Skip to content

Clinical trials

Hepatitis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: United Kingdom Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20093
20121
20134
20141
20151
20172
20201
20211
20224
20233
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vir Biotechnology, Inc.7
Gilead Sciences5
GlaxoSmithKline2
Human Genome Sciences Inc.2
Novartis Pharmaceuticals2
Vital Therapies, Inc.2
AbbVie1
AusperBio Therapeutics Inc.1
Intercept Pharmaceuticals1
King's College Hospital NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis28
Hepatitis B, Chronic9
Hepatitis B7
Liver Diseases7
Hepatitis C6
Digestive System Diseases5
Hepatitis, Chronic5
Hepatitis C, Chronic4
Hepatitis D4
Hepatitis D, Chronic4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.